"Bak (and Bax) to the future"--of primary melanoma prognosis?

Martin Leverkus1, Harald Gollnick

  • 1Laboratory for Experimental Dermatology, Department of Dermatology and Venereology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany. leverkus@medizin.uni-magdeburg.de